Welcome to Greenberg Traurig’s Health Care & FDA Practice Bulletin, a collection of timely articles written by our attorneys that are focused on significant developments in health and FDA law.
Continue Reading Health Care & FDA Practice Bulletin No. 5
GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco
Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences. Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco
Greenberg Traurig Philadelphia Hosts Israeli Digital Health Summit Reception
Greenberg Traurig was pleased to play a key role in the recent Israeli Digital Health Summit in Philadelphia. GT hosted a reception for the Israeli companies, investors and other guests
Continue Reading Greenberg Traurig Philadelphia Hosts Israeli Digital Health Summit Reception
Draft Guidances Propose Reduced FDA Oversight of General Wellness Products and Medical Device Accessories
Decisions by the U.S. Food and Drug Administration (FDA) have a tremendous impact on Israeli-based medical and pharmaceutical companies that manufacture products that are marketed and sold in the United
Continue Reading Draft Guidances Propose Reduced FDA Oversight of General Wellness Products and Medical Device Accessories
Israeli Medical Device & BioPharma Innovations
Organized by Israel Ministry of Industry Trade and Labor to the U.S., Greenberg Traurig will be hosting an Israeli Medical Device and Bio-Pharma delegation on Tuesday, December 10th from 8-10
Continue Reading Israeli Medical Device & BioPharma Innovations
Greenberg Traurig Announces Life Sciences & Medical Technology Newsletter
Welcome to the first issue of the Greenberg Traurig Life Sciences & Medical Technology Newsletter, a quarterly collection of articles and Alerts written by GT attorneys and focused on
Continue Reading Greenberg Traurig Announces Life Sciences & Medical Technology Newsletter